Skip to main content
SHIFT Newsroom
Read the latest published stories →Medicine news and evidence →

Ozempic Weight Loss Plateau: UK Six Month Review and Safe Next Steps

Published 12 October 2026 · SHIFT Team

Hand-drawn title card for plateau review

A weight loss plateau on Ozempic is common and expected for many people partway through treatment, not a sign that anything has gone wrong. The first two things worth doing are booking a clinician review to check your adherence and safety, and auditing your own habits honestly before touching your dose. Never adjust your dose yourself, and treat any new severe symptoms as urgent.

TL;DR:

- A true plateau lasts several weeks, and a semaglutide trial found stalling commonly around weeks 60 to 68, though individual timing varies.
- NICE recommends considering treatment discontinuation if weight loss remains below 5% of starting weight after six months on the maintenance dose.
- Prioritize consistent injection storage and timing, adequate protein, and resistance training two or three times weekly; track portions, liquid calories, sleep, stress, and alcohol.
- Seek urgent care for severe, persistent abdominal pain, especially if it radiates to your back; vomiting, dehydration, and low blood sugar symptoms warrant attention.
- Stopping semaglutide often leads to weight regain, and the withdrawal trial found continued treatment sustained further loss while placebo switching did not.

Table of Contents

What an Ozempic plateau actually is and when it tends to appear

A plateau means your weight has stopped falling for several weeks despite sticking to your injections and your usual eating and activity pattern. It is not the same as a single week where the scale does not move. Bodies rarely lose weight in a straight line, so a short stall is normal. A genuine plateau is a sustained flattening over a period extending for several weeks.

Trial evidence gives a rough sense of timing. In a randomised withdrawal trial of weekly semaglutide, continued treatment produced further weight loss compared with switching to placebo, and a plateau commonly appeared around weeks 60 to 68 in that trial setting. That timing will not match everyone, but it shows that stalling later in treatment is built into how the drug tends to behave over time, not a personal failing.

Guidelines build a formal checkpoint around this pattern. NICE guidance for semaglutide sets a reassessment point at six months on the maintenance dose, which is exactly the stage where many people start to notice things slowing down.

What an Ozempic plateau actually is and when it tends to appear — overview diagram

Why plateaus happen: biology and behaviour both play a part

Most plateaus come from a mix of two things: how your body adapts to weight loss, and small shifts in daily habits that creep in without you noticing.

On the biological side, your body needs fewer calories to function once you weigh less, so the same food intake that drove weight loss early on can simply maintain you later. Reviews of obesity pharmacotherapy describe this metabolic adaptation alongside a loss of lean muscle mass during weight loss, which further lowers the energy your body burns at rest.

On the behavioural side, appetite suppression can ease slightly as your body adjusts, and small increases in portion size or snacking often slip in unnoticed. Activity levels sometimes drop too, particularly once initial motivation settles into routine.

Medication factors matter as well:

A plateau doesn't mean the medicine has stopped working. It usually means your body and your medicine have reached a new balance, and something needs to shift to move past it.

Clinical review and reassessment: what your clinician will check

A plateau is the right moment for a structured review rather than a guess at what to change. NICE guidance sets out a clear threshold here: if you have lost less than 5% of your starting weight after six months on the maintenance dose, stopping treatment should be considered because this suggests an insufficient response.

A thorough review usually covers:

The MHRA's updated safety guidance strengthened its warnings on acute pancreatitis for GLP-1 medicines, advising anyone with severe, persistent abdominal pain to seek medical attention straight away. A review visit is also the place to raise this if it applies to you.

Pro Tip: Write down your weight trend, any missed doses and new medicines before your appointment. It turns a vague "it's not working" conversation into a specific one your clinician can actually act on.

Dose changes should only happen under clinical supervision. Semaglutide dosing is titrated carefully, and the Gov is explicit that adjustments should be clinician-led, partly because of hypoglycaemia risk in people who are not diabetic.

Stepwise, evidence-based strategies to try when weight stalls

Before anything else, audit the basics. Missed injections, incorrect storage temperature and inconsistent timing between doses can all blunt the effect of your medicine without any obvious symptom to warn you.

  1. Check your technique and timing first. Confirm your pen storage, injection site rotation and weekly schedule match the guidance you were given.
  2. Protect your protein intake. Lean muscle tends to decline during weight loss, and inadequate protein makes that worse, which in turn lowers the calories your body burns at rest, according to reviews of weight maintenance.
  3. Track what you are actually eating and drinking. Liquid calories from juice, alcohol and flavoured coffees are easy to underestimate, and appetite suppression sometimes masks gradual portion creep.
  4. Add resistance training. Progressive strength work two or three times a week helps preserve the muscle mass that medication alone will not protect, supporting the energy expenditure that keeps weight loss moving.
  5. Change the stimulus with shorter, harder sessions. A few weeks of higher-intensity intervals can break a routine your body has adapted to, without needing more total exercise time.
  6. Look at sleep, stress and alcohol together. Poor sleep and chronic stress are linked with weight gain and harder-to-shift weight through their effect on appetite hormones and cravings, per the Harvard T.H. Chan School of Public Health. Alcohol adds calories and can undercut sleep quality on top of that.
  7. Review your medicine timing with food and other prescriptions. Some interactions and administration habits affect absorption or tolerability in ways worth raising with a clinician rather than guessing at.

Pro Tip: Adding two short strength sessions a week is often more useful during a plateau than adding more cardio. It protects the muscle mass that keeps your metabolism from slowing further.

If none of these changes shift things within a reasonable window, your clinician might consider a supervised dose adjustment or discuss an alternative licensed weight-management pathway. That decision sits with them, informed by your bloods, symptoms and response so far, never with self-adjustment at home.

When to contact a clinician urgently and what happens at review

Some symptoms need prompt attention rather than waiting for a scheduled review. The MHRA's strengthened pancreatitis warning and wider drug safety guidance point to a short list of red flags:

A review typically looks at your weight trend over recent weeks, basic bloods where relevant, and whether a referral to specialist weight-management services is appropriate. The likely outcomes are continued monitoring, a supervised change to your treatment, or stopping the medicine if the NICE six-month threshold applies to your case.

Long-term expectations: maintenance, stopping and regain

Semaglutide appears to work best as an ongoing treatment rather than a short course. The same withdrawal trial that showed plateauing around weeks 60 to 68 also found that people who continued treatment kept losing weight, while those switched to placebo did not maintain the same trajectory.

Stopping the medicine often brings some weight regain, which is why maintenance planning matters as much as the initial weight loss phase. Reviews of obesity pharmacotherapy describe this pattern consistently across potent weight-loss treatments. Ongoing behavioural support, whether or not you remain on medication, tends to matter just as much as the prescription itself.

Our view on plateaus and structured support

Some approaches are built around the idea that a plateau is a checkpoint, not a failure, and pair clinical review with practical food guidance, achievable movement, and progress tracking so a stall gets caught early rather than drifting for months unnoticed. Men are supported at this stage regardless of where they started treatment, because the honest answer to "why has this stopped working" usually needs a proper look at adherence, habits and safety together, not a guess.

— Matt O’Brien

How we can help you get past a plateau

Shift Some Timber Ltd

We offer a clinical assessment, a medication pathway delivered through regulated partners, and ongoing behavioural support built around Grub, Fit and Life Back, so a plateau gets a proper review rather than a shrug.

If food noise or compensatory eating is part of your plateau, a targeted nutrition stack from a partner such as Kikaboni's weight management range is worth discussing alongside your clinician, never as a substitute for review. Head to our weight-management medication pathway to check your eligibility and get a plan built around where you actually are.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

How do you break a plateau on Ozempic?

Start with a clinician review to rule out safety issues and confirm adherence, then focus on protein intake, resistance training and consistent injection technique. Most plateaus respond to tightening these basics before any dose change is considered, and NICE guidance sets a formal reassessment point at six months on maintenance dose.

Why have I stopped losing weight with Ozempic?

Plateaus usually come from a combination of metabolic adaptation, where your body needs fewer calories after weight loss, and small behavioural shifts like slightly larger portions or reduced activity. Missed doses or injection technique issues can also blunt the medicine's effect, so these are worth checking first.

How to shock your body out of a plateau?

There is no safe way to "shock" your body into losing weight faster, and self-adjusting your dose is not recommended. Short, higher-intensity exercise sessions and adding resistance training can change the stimulus your body is used to, while a clinician review checks whether anything medical needs addressing.

How can I get Ozempic to start working again?

Ozempic has not usually stopped working outright. An adherence and technique audit, alongside a clinical review of your dose and any new medicines, is the right first step, and any further dose change should only happen under clinical supervision.

Sources